loading
Schlusskurs vom Vortag:
$31.60
Offen:
$32
24-Stunden-Volumen:
37,973
Relative Volume:
0.05
Marktkapitalisierung:
$2.06B
Einnahmen:
$681.88M
Nettoeinkommen (Verlust:
$122.63M
KGV:
15.28
EPS:
2.11
Netto-Cashflow:
$220.18M
1W Leistung:
+0.21%
1M Leistung:
-6.87%
6M Leistung:
-6.63%
1J Leistung:
+5.62%
1-Tages-Spanne:
Value
$31.87
$32.30
1-Wochen-Bereich:
Value
$31.25
$32.32
52-Wochen-Spanne:
Value
$26.47
$41.61

Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile

Name
Firmenname
Harmony Biosciences Holdings Inc
Name
Telefon
(484) 539-9800
Name
Adresse
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
Name
Mitarbeiter
268
Name
Twitter
Name
Nächster Verdiensttermin
2024-10-29
Name
Neueste SEC-Einreichungen
Name
HRMY's Discussions on Twitter

Vergleichen Sie HRMY mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
HRMY
Harmony Biosciences Holdings Inc
32.21 2.06B 681.88M 122.63M 220.18M 2.11
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
446.49 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
522.51 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
321.96 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
558.87 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
241.11 28.51B 3.81B -644.79M -669.77M -6.24

Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-02 Fortgesetzt Oppenheimer Outperform
2025-02-11 Eingeleitet Deutsche Bank Buy
2024-12-17 Eingeleitet H.C. Wainwright Buy
2024-10-10 Fortgesetzt Raymond James Outperform
2024-09-10 Eingeleitet UBS Buy
2024-06-21 Eingeleitet Citigroup Buy
2024-01-02 Herabstufung BofA Securities Neutral → Underperform
2023-09-25 Herabstufung Goldman Neutral → Sell
2023-09-07 Eingeleitet Berenberg Buy
2023-04-20 Eingeleitet BofA Securities Neutral
2022-10-14 Hochstufung Janney Neutral → Buy
2022-10-14 Hochstufung Jefferies Hold → Buy
2022-08-03 Herabstufung Jefferies Buy → Hold
2022-07-13 Herabstufung Goldman Buy → Neutral
2022-07-07 Eingeleitet Mizuho Buy
2022-04-14 Eingeleitet Cantor Fitzgerald Overweight
2021-12-01 Eingeleitet Oppenheimer Outperform
2021-11-04 Eingeleitet Raymond James Outperform
2021-09-23 Eingeleitet Needham Buy
2021-03-29 Hochstufung Goldman Neutral → Buy
2020-09-14 Eingeleitet Goldman Neutral
2020-09-14 Eingeleitet Jefferies Buy
2020-09-14 Eingeleitet Piper Sandler Overweight
Alle ansehen

Harmony Biosciences Holdings Inc Aktie (HRMY) Neueste Nachrichten

pulisher
Jun 16, 2025

Lupin Concedes To Harmony On Generic Wakix With 2030 Launch Agreement - insights.citeline.com

Jun 16, 2025
pulisher
Jun 16, 2025

Harmony Biosciences Presents Promising Preclinical Data for Novel Narcolepsy Treatment - MyChesCo

Jun 16, 2025
pulisher
Jun 15, 2025

Rhumbline Advisers Increases Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World

Jun 15, 2025
pulisher
Jun 14, 2025

(HRMY) Investment Analysis - news.stocktradersdaily.com

Jun 14, 2025
pulisher
Jun 12, 2025

Equities Analysts Set Expectations for HRMY FY2026 Earnings - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Harmony Biosciences Presents Preclinical Data Demonstrating Sign - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Harmony Biosciences to begin human trials of narcolepsy drug in 2025 By Investing.com - Investing.com South Africa

Jun 11, 2025
pulisher
Jun 11, 2025

Harmony Biosciences to begin human trials of narcolepsy drug in 2025 - Investing.com Canada

Jun 11, 2025
pulisher
Jun 11, 2025

HRMY: Harmony Biosciences Shows Promising Preclinical Data for BP1.15205 | HRMY Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Harmony Biosciences (HRMY) Presents Preclinical Data Demonstrating Significant Wake-Promoting and Cataplexy-Suppressing Effects of BP1.15205 - StreetInsider

Jun 11, 2025
pulisher
Jun 11, 2025

Harmony Biosciences Presents Preclinical Data Demonstrating Significant Wake-Promoting and Cataplexy-Suppressing Effects of BP1.15205 in Narcolepsy at SLEEP 2025 - Business Wire

Jun 11, 2025
pulisher
Jun 11, 2025

Harmony Biosciences Holdings, Inc. (HRMY): A Bull Case Theory - MSN

Jun 11, 2025
pulisher
Jun 10, 2025

Harmony Biosciences Reaches Settlement with Lupin Over WAKIX® Patent Litigation - MSN

Jun 10, 2025
pulisher
Jun 10, 2025

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Acquired by California State Teachers Retirement System - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Transcript : Harmony Biosciences Holdings, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 03 - MarketScreener

Jun 09, 2025
pulisher
Jun 05, 2025

Harmony Biosciences settles patent litigation with Lupin By Investing.com - Investing.com South Africa

Jun 05, 2025
pulisher
Jun 05, 2025

Harmony Biosciences, Lupin reach agreement on Wakix generic launch - MSN

Jun 05, 2025
pulisher
Jun 05, 2025

Harmony Biosciences: If It Ain't Broke (NASDAQ:HRMY) - Seeking Alpha

Jun 05, 2025
pulisher
Jun 05, 2025

Harmony Biosciences Strengthens Patent Position With Favorable Settlement in ANDA Litigation - BioSpace

Jun 05, 2025
pulisher
Jun 05, 2025

Harmony Biosciences (HRMY) Settles Patent Dispute with Lupin | HRMY Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Harmony Biosciences settles patent litigation with Lupin - Investing.com Australia

Jun 05, 2025
pulisher
Jun 05, 2025

Harmony Biosciences Strengthens Patent Position With Favorable Settlement In ANDA Litigation - MarketScreener

Jun 05, 2025
pulisher
Jun 05, 2025

Harmony Biosciences Strengthens Patent Position With Favorable S - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Harmony Biosciences Strengthens Patent Position With Favorable Settlement in ANDA Litigation | HRMY Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 04, 2025

Harmony Biosciences to Participate in Goldman Sachs 46th Annual Global Healthcare Conference | HRMY Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Harmony Biosciences to Participate in Goldman Sachs 46th Annual Global Healthcare Conference - Yahoo Finance

Jun 04, 2025
pulisher
Jun 04, 2025

Top 5 US Stocks To Buy In June 2025 - Investing.com

Jun 04, 2025
pulisher
Jun 03, 2025

Harmony Biosciences (NASDAQ:HRMY) Now Covered by Analysts at Oppenheimer - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Where Harmony Biosciences Hldgs Stands With Analysts - Benzinga

Jun 02, 2025
pulisher
Jun 02, 2025

Oppenheimer Sets $61 Price Target for Harmony Biosciences (HRMY) | HRMY Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

(HRMY) On The My Stocks Page - news.stocktradersdaily.com

Jun 02, 2025
pulisher
Jun 02, 2025

Oppenheimer assumes Outperform rating on Harmony Biosciences stock By Investing.com - Investing.com Nigeria

Jun 02, 2025
pulisher
Jun 02, 2025

Oppenheimer assumes Outperform rating on Harmony Biosciences stock - Investing.com

Jun 02, 2025
pulisher
Jun 02, 2025

Harmony Biosciences (HRMY) Receives Outperform Rating from Oppen - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Oppenheimer Assumes Harmony Biosciences Holdings Inc. (HRMY) at Outperform - StreetInsider

Jun 02, 2025
pulisher
Jun 02, 2025

Oppenheimer Sets $61 Price Target for Harmony Biosciences (HRMY) - GuruFocus

Jun 02, 2025
pulisher
May 30, 2025

Nuveen Asset Management LLC Buys 8,193 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World

May 30, 2025
pulisher
May 28, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Grows Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World

May 28, 2025
pulisher
May 27, 2025

Bank of America Corp DE Decreases Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World

May 27, 2025
pulisher
May 27, 2025

Ameriprise Financial Inc. Purchases 18,730 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World

May 27, 2025
pulisher
May 27, 2025

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Average Recommendation of “Buy” by Analysts - Defense World

May 27, 2025
pulisher
May 23, 2025

When (HRMY) Moves Investors should Listen - news.stocktradersdaily.com

May 23, 2025
pulisher
May 22, 2025

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Bought by Deutsche Bank AG - Defense World

May 22, 2025
pulisher
May 20, 2025

A Piece Of The Puzzle Missing From Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) 26% Share Price Climb - simplywall.st

May 20, 2025
pulisher
May 18, 2025

BNP Paribas Financial Markets Invests $2.03 Million in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World

May 18, 2025
pulisher
May 18, 2025

Harmony Biosciences (NASDAQ:HRMY) Price Target Raised to $48.00 - Defense World

May 18, 2025
pulisher
May 16, 2025

The Manufacturers Life Insurance Company Acquires 2,144 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World

May 16, 2025
pulisher
May 16, 2025

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Stock Position Increased by Northern Trust Corp - Defense World

May 16, 2025
pulisher
May 16, 2025

Comerica Bank Acquires 2,919 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World

May 16, 2025
pulisher
May 16, 2025

Harmony Biosciences (NASDAQ:HRMY) Upgraded at Cantor Fitzgerald - Defense World

May 16, 2025
pulisher
May 15, 2025

Harmony Biosciences (HRMY): Mizuho Raises Price Target to $48 | - GuruFocus

May 15, 2025

Finanzdaten der Harmony Biosciences Holdings Inc-Aktie (HRMY)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.48
price down icon 0.77%
$35.97
price down icon 0.17%
$21.22
price down icon 0.14%
$99.67
price down icon 1.11%
$106.30
price down icon 0.08%
biotechnology ONC
$241.30
price up icon 0.06%
Kapitalisierung:     |  Volumen (24h):